Sorry, you need to enable JavaScript to visit this website.

A Study to Learn If Tanezumab Could Lessen Metastatic Bone Pain in Participants Who Were Taking Opioids

A Study to Learn If Tanezumab Could Lessen Metastatic Bone Pain in Participants Who Were Taking
Opioids. A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Analgesic Efficacy and Safety of the Subcutaneous Administration of Tanezumab (PF-04383119) in Subjects With Cancer Pain Predominantly due to Bone Metastasis Receiving Background Opioid Therapy.

Category & Conditions: Cancer
Medicine: tanezumab
ClinicalTrials.gov Identifier (NCT): NCT02609828
Protocol ID: A4091061
    Share
PrintDownload
Open Plain Language Summary Result: Click here